BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25077997)

  • 1. Impact of tumor removal on the systemic oxidative profile of patients with breast cancer discloses lipid peroxidation at diagnosis as a putative marker of disease recurrence.
    Herrera AC; Victorino VJ; Campos FC; Verenitach BD; Lemos LT; Aranome AM; Oliveira SR; Cecchini AL; Simão AN; Abdelhay E; Panis C; Cecchini R
    Clin Breast Cancer; 2014 Dec; 14(6):451-9. PubMed ID: 25077997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer.
    Panis C; Victorino VJ; Herrera AC; Freitas LF; De Rossi T; Campos FC; Simão AN; Barbosa DS; Pinge-Filho P; Cecchini R; Cecchini AL
    Breast Cancer Res Treat; 2012 Jun; 133(3):881-8. PubMed ID: 22048816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy.
    Panis C; Herrera AC; Victorino VJ; Campos FC; Freitas LF; De Rossi T; Colado Simão AN; Cecchini AL; Cecchini R
    Breast Cancer Res Treat; 2012 May; 133(1):89-97. PubMed ID: 21811816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues.
    Wang M; Dhingra K; Hittelman WN; Liehr JG; de Andrade M; Li D
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):705-10. PubMed ID: 8877062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human epidermal growth factor receptor-2 positivity predicts locoregional recurrence in patients with T1-T2 breast cancer.
    Cefaro GA; Genovesi D; Trignani M; DI Nicola M
    Anticancer Res; 2014 Mar; 34(3):1207-12. PubMed ID: 24596361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between membrane lipid peroxidation, transglutaminase activity, and cyclooxygenase 2 expression in the tissue adjoining to breast cancer.
    Balestrieri ML; Dicitore A; Benevento R; Di Maio M; Santoriello A; Canonico S; Giordano A; Stiuso P
    J Cell Physiol; 2012 Apr; 227(4):1577-82. PubMed ID: 21678409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased oxidative damage to membrane lipids following surgery for breast cancer.
    Szychta P; Zadrozny M; Lewinski A; Karbownik-Lewinska M
    Neuro Endocrinol Lett; 2014; 35(7):602-7. PubMed ID: 25617883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid peroxidation and altered anti-oxidant status in breast adenocarcinoma patients.
    Wang C; Yu J; Wang H; Zhang J; Wu N
    Drug Res (Stuttg); 2014 Dec; 64(12):690-2. PubMed ID: 25050522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
    Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L
    Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma.
    Lê MG; Arriagada R; Spielmann M; Guinebretière JM; Rochard F
    Cancer; 2002 Jun; 94(11):2813-20. PubMed ID: 12115367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer.
    Lowery AJ; Sweeney KJ; Molloy AP; Hennessy E; Curran C; Kerin MJ
    BMC Cancer; 2008 Sep; 8():279. PubMed ID: 18826631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy.
    Kreike B; Halfwerk H; Kristel P; Glas A; Peterse H; Bartelink H; van de Vijver MJ
    Clin Cancer Res; 2006 Oct; 12(19):5705-12. PubMed ID: 17020974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Breast Tumors Affect the Oxidative Status of the Surrounding Environment? A Comparative Analysis among Cancerous Breast, Mammary Adjacent Tissue, and Plasma.
    Panis C; Victorino VJ; Herrera AC; Cecchini AL; Simão AN; Tomita LY; Cecchini R
    Oxid Med Cell Longev; 2015; 2015():6429812. PubMed ID: 26697139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
    Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
    Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of HER2neu in ductal carcinoma in situ is associated with local recurrence.
    Han K; Nofech-Mozes S; Narod S; Hanna W; Vesprini D; Saskin R; Taylor C; Kong I; Paszat L; Rakovitch E
    Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):183-9. PubMed ID: 21958729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid peroxidation and total antioxidant status in patients with breast cancer.
    Sener DE; Gönenç A; Akinci M; Torun M
    Cell Biochem Funct; 2007; 25(4):377-82. PubMed ID: 16447143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
    Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
    Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period.
    Fortunato L; Mascaro A; Poccia I; Andrich R; Amini M; Costarelli L; Cortese G; Farina M; Vitelli C
    Ann Surg Oncol; 2012 Apr; 19(4):1107-14. PubMed ID: 21913022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diet and oxidative stress in breast, colon and prostate cancer patients: a case-control study.
    Hietanen E; Bartsch H; Béréziat JC; Camus AM; McClinton S; Eremin O; Davidson L; Boyle P
    Eur J Clin Nutr; 1994 Aug; 48(8):575-86. PubMed ID: 7957003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 8-epimer of prostaglandin F(2alpha), a marker of lipid peroxidation and oxidative stress, is decreased in the nipple aspirate fluid of women with breast cancer.
    Mannello F; Tonti GA; Pagliarani S; Benedetti S; Canestrari F; Zhu W; Qin W; Sauter ER
    Int J Cancer; 2007 May; 120(9):1971-6. PubMed ID: 17266038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.